STATERA BIOPHARMA INC (STAB)
US8575611046 - Common Stock
| TTM (2022-9-30) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | 2018 (2018-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -91.86M | -101.88M | -2.44M | -3.16M | -3.71M | |||
| Depreciation Amortization | 556.31K | 255.57K | 11.45K | 13.78K | 18.18K | |||
| Income Taxes - Deferred | N/A | 373.47K | N/A | N/A | N/A | |||
| Change In Working Capital | 13.16M | 850.72K | 173.64K | 607.92K | 105.33K | |||
| Interest Paid | 1.51M | 1.25M | N/A | 0.00 | 0.00 | |||
| Other non cash items | 65.68M | 72.20M | -120.20K | -122.42K | -1.03M | |||
| OPERATING CASH FLOW | -12.09M | -28.19M | -2.37M | -2.66M | -4.61M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -103.36K | -182.97K | N/A | -1.55K | -27.88K | |||
| Other Investing Activity | N/A | 13.65M | 55.44K | 158.33K | 3.99M | |||
| INVESTING CASH FLOW | -103.36K | 13.46M | 55.44K | 156.78K | 3.97M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | -9.60M | 13.64M | N/A | N/A | N/A | |||
| Stock Issued/Repurchased | 8.06M | 7.34M | 3.17M | 0.00 | 55.22K | |||
| Other Financing Activity | N/A | N/A | N/A | N/A | N/A | |||
| FINANCING CASH FLOW | -1.60M | 20.99M | 3.17M | 0.00 | 55.22K | |||
| Exchange Rate Effect | 81.44K | -6.65K | -27.80K | 15.50K | -21.75K | |||
| CHANGE IN CASH | -13.71M | 6.25M | 820.29K | -2.49M | -613.32K | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -12.09M | -28.19M | -2.37M | -2.66M | -4.61M | |||
| Capital Expenditure | -103.36K | -182.97K | N/A | -1.55K | -27.88K | |||
| FREE CASH FLOW | -12.19M | -28.38M | -2.37M | -2.66M | -4.64M | |||
All data in USD